Previous Close | 3.35 |
Open | 3.40 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 3.40 - 3.72 |
52 Week Range | 1.87 - 4.29 |
Volume | 162,180 |
Avg. Volume | 87,623 |
Market Cap | 120.197M |
Beta | -1.34 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.17 |
Earnings Date | May 14, 2018 - May 18, 2018 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.17 |
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product, today announced the launch of Renuvion™, a new brand that is dedicated to the cosmetic surgery market.
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product, today announced the appointment of Scott R.
On a per-share basis, the Purchase, New York-based company said it had a loss of 3 cents. The medical device maker posted revenue of $11.3 million in the period. For the year, the company reported that ...
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product, today reported financial results for its fourth quarter and full year ended December 31, 2017.
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product, today announced the appointment of Craig A.
NEW YORK, NY / ACCESSWIRE / March 12, 2018 / Bovie Medical Corporation (Nyse American: BVX ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 12, 2018 at 4:30 PM ...
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced the appointment of Dr.
Bovie Medical , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the fourth quarter and fiscal year of 2017 will be released after the market closes on Monday, March 12.
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that it has enrolled the first patient in a U.S.
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that Charles D.
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that management will parti
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Bovie Medical Corp. Here are 5 ETFs with the largest exposure to BVX-US. Comparing the performance and risk of Bovie Medical Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
On a per-share basis, the Purchase, New York-based company said it had a loss of 4 cents. The medical device maker posted revenue of $9.3 million in the period. Bovie expects full-year revenue in the range ...
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today reported financial results for its third fiscal quarter ended September 30, 2017.
NEW YORK, NY / ACCESSWIRE / November 2, 2017 / Bovie Medical Corporation (NYSE American: BVX ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 2, 2017 at 4:30 ...
While small-cap stocks, such as Bovie Medical Corporation (AMEX:BVX) with its market cap of USD $123.13M, are popular for their explosive growth, investors should also be aware of their balanceRead More...
Bovie Medical , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the third quarter of 2017 will be released after the market closes on Thursday, November 2.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Bovie Medical Corp. Here are 5 ETFs with the largest exposure to BVX-US. Comparing the performance and risk of Bovie Medical Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that management will participate in the Wedbush PacGrow Healthcare Conference at the Le Parker Meridien Hotel in New York, New York.